Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Nuvance advances to phase II clinical trials for long-term control of asthma

March 3, 1999

HFA-134a-BDP controls asthma at half the dose of traditional inhalers

March 3, 1999

Licensing opportunity from BTG: xanthine oxidase inhibitors for treatment of ARDS

March 3, 1999

PDE4 inhibitors claimed by Byk Gulden for airways disorders

March 3, 1999

PPL's initial results of AAT trial in cystic fibrosis

March 1, 1999

Licensing opportunity from BTG: antiasthmatic compound with a novel mechanism of action

March 1, 1999

Clinical trial shows HP-3 effective in COPD

March 1, 1999

Taiwan university researchers present new ATP-sensitive potassium channel opener

Feb. 25, 1999

Tachykinin antagonists specifically claimed for asthma by Merck

Feb. 25, 1999

Purinoceptor antagonists claimed by Astra, useful for inflammatory diseases

Feb. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...